ananthapavan-costeffectivenessrivaroxaban-2012.pdf (458.59 kB)
Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism : a Canadian analysis using the Ontario Ministry of Health perspective
journal contribution
posted on 2012-10-01, 00:00 authored by H McDonald, A Diamantopoulos, P Wells, M Lees, K Folkerts, F Forster, Jaithri AnanthapavanJaithri AnanthapavanCost-effectiveness of rivaroxaban in the prevention of venous thromboembolism : a Canadian analysis using the Ontario Ministry of Health perspective
History
Journal
Journal of medical economicsVolume
15Issue
5Season
Article JME-684116/684116Pagination
817 - 828Publisher
Informa HealthcareLocation
London, EnglandPublisher DOI
ISSN
1369-6998eISSN
1941-837XLanguage
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2012, Informa HealthcareUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC